Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

17.80

-0.15 (-0.84%)

At close: Mar 6, 2026, 4:00 PM EST

17.99

+0.19 (1.07%)

After-hours: Mar 6, 2026, 6:46 PM EST

Monte Rosa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	208.34	224.25	128.1	54.91	346.07	41.7
Short-Term Investments	182.92	147.9	104.31	207.91	-	-
Cash & Short-Term Investments	391.26	372.15	232.41	262.83	346.07	41.7
Cash Growth	61.55%	60.12%	-11.57%	-24.05%	729.93%	595.56%
Other Receivables	4.97	0.17	0.51	7.66	-	-
Total Trade Receivables	4.97	0.17	0.51	7.66	-	-
Other Current Assets	5.59	5.12	3.29	5.4	2.6	1.89
Total Current Assets	401.82	377.44	236.21	275.89	348.67	43.59
Net Property, Plant & Equipment	52.66	56.31	62.61	61.91	12.33	4.62
Other Long-Term Assets	5.36	4.98	4.93	4.6	5.34	1.16
Total Assets	459.84	438.73	303.76	342.39	366.33	49.38
Accounts Payable	14.51	17.22	11.15	7.86	6.56	7.07
Accrued Expenses	17.9	18.79	14.6	14.58	10.08	2.53
Current Portion of Leases	4.24	3.71	3.16	3.13	-	-
Unearned Revenue	24.79	117.23	17.68	-	-	-
Other Current Liabilities	-	-	-	-	-	19.68
Total Current Liabilities	61.44	156.95	46.59	25.57	16.64	29.28
Long-Term Leases	35.93	39	42.88	43.87	-	-
Other Long-Term Liabilities	116.63	19.85	35.04	1.53	2.18	1.07
Total Long-Term Liabilities	152.56	58.85	77.91	45.41	2.18	1.07
Total Liabilities	214	215.8	124.51	70.98	18.81	30.34
Common Stock	0.01	0.01	0	0.01	0.01	0
Additional Paid-in Capital	680.16	664.87	547.86	503.7	471.57	0.4
Accumulated Other Comprehensive Income	-3.25	-3.36	-2.72	-1.75	-2.02	-1.06
Retained Earnings	-431.08	-438.59	-365.89	-230.54	-122.04	-48.08
Total Common Shareholders' Equity	245.84	222.94	179.25	271.41	347.52	-48.73
Minority Interest	-	-	-	-	-	67.76
Shareholders' Equity	245.84	222.94	179.25	271.41	347.52	19.04
Total Liabilities & Equity	459.84	438.73	303.76	342.39	366.33	49.38
Total Debt	40.17	42.72	46.04	47	0	0
Net Cash (Debt)	351.09	329.43	186.37	215.83	346.07	41.7
Net Cash Growth	6.57%	76.76%	-13.65%	-37.64%	729.93%	695.02%
Net Cash Per Share	4.26	4.46	3.63	4.57	13.84	27.49
Book Value	245.84	222.94	179.25	271.41	347.52	-48.73
Book Value Per Share	2.98	3.02	3.49	5.75	13.90	-32.12
Tangible Book Value	245.84	222.94	179.25	271.41	347.52	-48.73
Tangible Book Value Per Share	2.98	3.02	3.49	5.75	13.90	-32.12

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q